autologous engineered skin substitute
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT01655407)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous engineered skin substitute
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01655407 | Phase 2 | Sep 1, 2016 | Amarantus BioScience Holdings, Inc., Amarex Clinical Research, University of Arizona |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amarantus BioScience Holdings, Inc. | For profit | 1 | 1 | 1 | 2016 |
| Amarex Clinical Research | For profit | 1 | 0 | 1 | 2016 |
| University of Arizona | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1